US Patent Issued to RENA THERAPEUTICS on Dec. 9 for "Nucleic acid complex for regulating IHH expression" (Japanese Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,399, issued on Dec. 9, was assigned to RENA THERAPEUTICS INC. (Tokyo).

"Nucleic acid complex for regulating IHH expression" was invented by Hideki Kizawa (Tokyo) and Ko Takagi (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a nucleic acid complex and a method for decreasing the expression levels of mRNA and a protein of the IHH gene in animals. The nucleic acid complex for decreasing the expression levels of mRNA and a protein of the IHH gene serves as an IHH-specific inhibitor and it is thus useful for elucidation of IHH gene functions. In addition, an IHH-specific inhibitor is useful for treatment, prevention, ameliora...